文献詳細
今月の臨床 HPVワクチン勧奨再開―いま知りたいことのすべて
世界の趨勢と特殊な集団への接種
文献概要
●世界保健機関(WHO)は,HPVワクチンを全世界で国の接種プログラムとして実施すべきとし,9〜14歳の女子への2回接種を推奨している(日本では3回接種).
●子宮頸がんの世界的な排除に向け,90%の女子が15歳までにHPVワクチン,70%の女性が35歳・45歳までに2回の検診,90%の子宮頸がん患者の治療の3つが必要である.
●男性へのHPVワクチン接種もgender-neutral vaccinationとして50以上の国がプログラムに導入し,有効性と費用対効果のデータが蓄積されつつある.
●子宮頸がんの世界的な排除に向け,90%の女子が15歳までにHPVワクチン,70%の女性が35歳・45歳までに2回の検診,90%の子宮頸がん患者の治療の3つが必要である.
●男性へのHPVワクチン接種もgender-neutral vaccinationとして50以上の国がプログラムに導入し,有効性と費用対効果のデータが蓄積されつつある.
参考文献
1)World Health Organization : Human papillomavirus vaccines : WHO position paper, May 2017-Recommendations. Vaccine 35 : 5753-5755, 2017http://apps.who.int/iris/bitstream/handle/10665/255353/WER9219.pdf;jsessionid=FEE8EA93C54035296D650A2ECD0FA203?sequence=1
2)Dobson SR, et al : Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women : a randomized clinical trial. JAMA 309 : 1793-1802, 2013
3)WHO : Global strategy to accelerate the elimination of cervical cancer as a public health problem. 17November, 2020 https://www.who.int/publications/i/item/9789240014107
4)Simms KT, et al : Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99 : a modelling study. Lancet Oncol 20 : 394-407, 2019
5)Canfell K, et al : Mortality impact of achieving WHO cervical cancer elimination targets : a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 395 : 591-603, 2020
6)Brisson M, et al : Impact of HPV vaccination and cervical screening on cervical cancer elimination : a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 395 : 575-590, 2020
7)Bailey HH, et al : American Society of Clinical Oncology Statement : Human papillomavirus vaccination for cancer prevention. J Clin Oncol 34 : 1803-1812, 2016
8)Arrossi S, et al : Primary prevention of cervical cancer : American Society of Clinical Oncology Resource-Stratified Guideline. J Global Oncol 3 : 611-634, 2017
9)Chow EPF, et al : Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme : an analysis of national sentinel surveillance data from 2004-18. Lancet Infect Dis 21 : 1747-1756, 2021
10)Linertová R, et al : Cost-effectiveness of extending the HPV vaccination to boys : a systematic review. J Epidemiol Community Health 75 : 910-916, 2021
11)Majed L, et al : Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France. Vaccine 39 : 438-446, 2021
12)De la Fuente J, et al : Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain. Hum Vaccin Immunother 15 : 1949-1961, 2019
13)UK Health Security Agency : HPV vaccination : guidance for healthcare practitioners(version 4). last update 7 April, 2022https://www.gov.uk/government/publications/hpv-universal-vaccination-guidance-for-health-professionals
14)Falcaro M, et al : The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence : a register-based observational study. Lancet 398 : 2084-2092, 2021
15)Lei J, et al : HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 383 : 1340-1348, 2020
16)Kjaer SK, et al : Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst 113 : 1329-1335, 2021
17)Meites E, et al : Human papillomavirus vaccination for adults : updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 68 : 698-702, 2019 https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/hpv.html
18)Tabibi T, et al : Human papillomavirus vaccination and trends in cervical cancer incidence and mortality in the US. JAMA Pediatr 176 : 313-316, 2021
19)Australian Government Department of Health : Human papillomavirus(HPV). Information about human papillomavirus(HPV)disease, vaccines and recommendations for vaccination from the Australian Immunisation Handbook. 4 June 2018. https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/human-papillomavirus-hpv
20)Hall MT, et al : The projected timeframe until cervical cancer elimination in Australia : a modelling study. Lancet Public Health 4 : e19-e27, 2019
掲載誌情報